In lichenified AD, IL-13–TGF-β crosstalk mediated fibroblast activation and thickening, challenging the sufficiency of anti-inflammatory monotherapy [289,291], underscoring the need for antifibrotic or combinatorial therapeutic strategies (Table 1). Here, IL13 is linked to Alzheimer disease.